Skip to content
DeepViews

RadNet, Inc. Common Stock (RDNT) — Analysis Summary

RadNet, Inc. Common Stock (RDNT) has a market cap of $5.63B with year-over-year revenue growth of +11.5%. Net margin stands at -0.9%. The stock trades at a P/E ratio of -266.4.

Key Takeaways

  • Revenue changed +11.5% year-over-year
  • Net margin of -0.9%
  • P/E ratio of -266.4

Compared to other companies in the SERVICES-MEDICAL LABORATORIES sector, RDNT posted revenue growth of +11.5% and trades at a P/E of -266.4.

[XNAS]

RadNet, Inc. Common Stock (RDNT)

$71.49

PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$5626.10M
Enterprise Value
$6237.98M
P/E Ratio
-266.4
Div Yield
0.00%
EV/EBITDA
25.8
Company Profile
About
About RadNet, Inc. Common Stock

RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.

Sector

SERVICES-MEDICAL LABORATORIES

Employees

11,264

Headquarters

LOS ANGELES, CA

Exchange

XNAS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
44
Narrow Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$1394.05M
Total Debt$1338.15M
Debt-to-Equity0.96
Cash & Equivalents$726.27M

Cash Flow

Operating Cash Flow$310.06M
Free Cash Flow$72.37M
FCF Margin3.19%
P/FCF Ratio77.74
Source: Polygon.io · SEC EDGAR
Dividends
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.